Krishnan J, Patel A, Roy AM, Alharbi M, et al. Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience. Clin Breast Cancer 2024 Aug 6:S1526-8209(24)00217.
PMID: 39198116